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EpidemicsWe tried to reveal the strain speciﬁcity of neutralizing mAbs against H3N2 inﬂuenza viruses in individuals. A
large number of B lymphocytes of a pediatrician were collected by apheresis and two Ab libraries were
constructed at 2004 and 2007 by using the phage-display technology. The libraries were screened against 12
different H3 strains of ﬂu isolated between 1968 and 2004. Large numbers of clones that bound to the Ags
were isolated and mAbs that speciﬁcally bound to H3 strain viruses were selected. Their binding activity to
the 12 strains and neutralizing activity were studied by ELISA and focus reduction test, respectively.
Furthermore, the binding activity to hemagglutinin (HA) was examined by Western blot. The majority of
clones showing the neutralizing activity turned out to be anti-HA mAbs and could be divided into three
major groups showing distinct strain speciﬁcity: 1968–1973, 1977–1993 and 1997–2003.
© 2009 Elsevier Inc. All rights reserved.Introduction
Inﬂuenza viruses are made of nine structural viral proteins of
which three are membrane proteins, hemagglutinin (HA), neuramin-
idase and matrix protein 2 (Webster et al., 1992). Abs play important
roles in protection against and recovery from inﬂuenza virus infection
while HA is the main target for virus-neutralizing Abs (Epstein et al.,
1993; Gerhard et al., 1997; Palladino et al., 1995). Based on the
differences in the reactivity of HA against Abs that have been prepared
by immunization with respective viruses, inﬂuenza A viruses are
classiﬁed into 16 subtypes (Fouchier et al., 2005). Last century, H1, H2
and H3 subtype viruses infected human and caused three major
pandemics, ‘Spanish’ inﬂuenza, ‘Asian’ inﬂuenza and ‘Hong Kong’ience, Fujita Health University,
-1192, Japan. Fax: +81 562 93
wa).
ll rights reserved.inﬂuenza, respectively (Palese, 2004). In addition to pandemics,
epidemics of inﬂuenza occur nearly every year due to mutations that
cause changes in the HA leading to new viral variants that are no
longer recognized by the preexisting Abs (Hay et al., 2001). However,
to the best of our knowledge very little is known about the nature and
range of protective monoclonal Abs (mAbs) that are generated in an
infected individual and what kind of Ag speciﬁcity the mAbs show.
In our studies we tried to reveal the repertoire of neutralizing mAbs
against inﬂuenza viruses. Since the outbreak of ‘Hong Kong’ inﬂuenza in
1968, H3N2 inﬂuenza viruses remained the most common cause of ﬂu.
Using thephage-display technology (Winter et al., 1994)weconstructed
the Ab libraries from the B lymphocytes of a pediatrician who has been
repeatedly immunized and exposed to inﬂuenza viruses. From the Ab
libraries we isolated mAbs against viral proteins of 12 different H3
strains isolated between 1968 and 2004 and studied their binding to the
12 strains and neutralizing activities. Since we collected B lymphocytes
from the same person twice at 3-year intervals (2004 and 2007) and
independently constructed two Ab libraries, we were able to compare
the clones isolated from themand consider the relevanceof our strategy.
Table 1
Summary of screenings.a
Virus strains Library
2004 2007
1968 78b 74
1970 177 –
1973 214 –
1977 85 –
1981 160 –
1985 28 –
1989 74 –
1993 50 –
1997 58 43
1999 68 71
2003 43 55
2004 108 25
Total 1143 268
a Two libraries (2004 and 2007) were screenings against 12 and 5 kinds of H3 strains
that had been isolated between 1968 and 2004, respectively.
b Number of clones that were isolated and turned out to speciﬁcally bind to the H3
virus strain in each screening was indicated.
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Isolation of mAbs that speciﬁcally bound to H3 strain viral proteins
Mononuclear cells were collected by apheresis from a pediatrician
(born in 1960) who has been vaccinated every year against inﬂuenza
and often exposed to ﬂu-infected patients. The ﬁrst apheresis was
performed in June of 2004 and the second one was in April of 2007.
Each pooled fraction contained approximately 109 B lymphocytes.
Using the phage-display method (Winter et al., 1994), we constructed
two (2004 and 2007) large combinatorial Ab libraries composed of
about 3×1010 independent clones. The 2004 library was screened
against the 12 different H3 strains that had been isolated between
1968 and 2004. The 2007 library was screened against 5 of those 12
H3 strains. Screenings were separately performed for each strain.
After 5376 and 1850 clones in total were isolated from the 2004 and
2007 libraries, respectively, the mAbs that bound to H3 strain virus
particles and did not bind to H1 virus in ELISAwere selected. The 1143
clones from the 2004 library and 268 from the 2007 library
summarized in Table 1 were subjected to further analyses.
Classiﬁcation of clones by sequencing
VH nucleotide sequences of all these clones were determined.
Comparison of the amino acid sequences among the 1143 clones from
the 2004 library revealed that they were composed of 153 unique
mAbs with different VH sequences. Similarly, the 268 clones from the
2007 library were composed of 68 unique mAbs. Based on sequence
similarities of VH fragments, in particular the comparison of CDR3
sequences, the 153 clones were classiﬁed into 65 groups. All the VH
and VL sequences of these 153 clones from the 2004 library were
available in Supplementary Fig. 1.
Binding activity and virus-neutralizing activity
The binding activity of 153 mAbs from the 2004 library to the
viral proteins of the 12 distinct H3 strains was examined by ELISA.
Their virus-neutralizing activity was also analyzed by focus
reduction test. The 153 mAbs were largely divided into two
categories. Of the 153 clones 113 clones classiﬁed into groups 1–
31 showed not only binding activity but also neutralizing activity
(category 1) while the remaining 40 clones classiﬁed into group 32–
65 showed only binding activity (category 2), as indicated in Figs. 1
and 2, respectively.
Here we pointed out three distinct characteristics of the results
shown in Fig. 1. 1. For respective clones the strain speciﬁcity ofbinding activity marked by red is not exactly the same as but roughly
similar to that of neutralizing activity marked by dark blue in most
cases. 2. The strain speciﬁcity of the two activities is similar to each
other among the clones belonging to the same group. 3. Majority of
the clones were divided into three types showing distinct strain
speciﬁcity: 1968–1973, 1977–1993 and 1997–2003.
HA-binding activity
In order to identify molecules recognized by respective clones,
Western blot of virus proteins used as Ags with representative clones
of each group was performed. The results were indicated in the right
end column of Figs. 1 and 2. The raw data of Western blot were
shown in Supplementary Fig. 2. When Ab bound to HA in Western
blot under nonreducing conditions, three bands were detected such
as one major band at around 75 kb, two minor bands at around 180
kb and 250 kb that could correspond to monomer, dimer and trimer
of HA, respectively, as indicated by the positive control using anti-HA
mouse IgG (Vanlandschoot et al., 1995). All the clones classiﬁed into
category 1 turned out to be anti-HA mAbs except for clones
belonging to group 30 which showed broad strain speciﬁcity of
binding and neutralizing activities from 1970 to 2004 strains. While
the clones of group 30 gave one major band at around 250 kb and
one weak band at around 130 kb, it has not been revealed yet what
they were. In the case of clones classiﬁed into category 2, only three
clones belonging to group 36, 37 and 44 were anti-HA mAbs. The Ags
recognized by the other clones could not yet be identiﬁed by the
Western blot.
Comparison of clones isolated from the 2007 library with clones from the
2004 library
The VH amino acid sequences of the 68 unique mAbs isolated from
2007 library were compared with those of the 153 clones classiﬁed
into 65 groups isolated from 2004 library. If the clone isolated from
the 2007 library could be classiﬁed into one of the 65 groups, we
judged that the 2007 library-derived clone overlapped with the 2004
library-derived clones. All the VH and VL sequences of these 68 clones
from the 2007 library were also shown in Supplementary Fig. 1. The
binding activity of the 68 clones to the 12 strains was examined by
ELISA and the Ags recognized by these clones were analyzed by
Western blot. All the results were indicated in Fig. 3. Since we used
only 5 strains as indicated in Table 1, mAbs that bound to ﬁve strains
from 1977 to 1993 and belonged to group 5–19were not isolated from
the 2007 library. However, 47 out of 68 unique clones (69%)
overlapped with those from the 2004 library that belonged to group
1, 3, 20, 22, 23, 25, 26, 27, 29, 33, 36 and 52 (Figs. 1–3). The strain
speciﬁcity of binding activity shown by the overlapped clones seemed
to be well conserved between the 2004- and 2007-derived ones. The
results of Western blot were not contradictory to each other except
for clones belonging to group 52. While group 52 clone from the 2004
library did not bind to HA in Western blot, that from the 2007 library
gave positive signals at the HA positions.
Analyses of IgG1 form of mAbs
The two clones [F004-104 (group 20) and F004-136 (group 24)]
were converted into IgG1 and used for comparative studies of
neutralizing activity between monovalent Fab and divalent IgG. As
indicated in Fig. 4A the complete Abs gave a thousand to several
thousand-fold higher neutralizing activities than the Fab fragment.
The concentration of IgG form of mAbs required for 50% reduction in
focus formation was about 0.01–0.03 nM. While Fab form of clone
F004-104 neutralized only three strains 1997, 1999 and 2003 (Fig. 1),
IgG form of the Ab neutralized four strains 1993 to 2003 (Fig. 4B). This
apparent discrepancy could be explained by differences in the
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Fig. 2. The binding activity of 40 unique mAbs isolated from the 2004 library. The binding activity to the 12 H3N2 strains was examined. The results of binding activity of the 40mAbs
classiﬁed into group 32 to group 65 in category 2 that did not have neutralizing activity were indicated. The results were presented in the same way as in Fig. 1.
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strain is several-ten times less active compared with the other 3
strains of 1997, 1999 and 2003 (Fig. 4B). Moreover the Fab form of Ab
showed the positive binding activity assayed by ELISA against 1993
strain (Fig. 1). Therefore, the neutralizing activity shown by Fab Ab at
100 μg/ml (it corresponded to 1.5 μM) could have been under the
detectable level. IgG form of F004-136 neutralized three strains 1997,
1999 and 2003 (Fig. 4B). In the case of the Fab form, although the
strain speciﬁcity of the neutralizing activity was not clear, the analysis
of the binding activity indicated that it bound to the three strains
(Fig. 1). Thus, we judged that conversion from Fab to IgG1 did not
largely change the Ag speciﬁcity.
Using the IgG1 form of mAbs we also looked for escape mutants of
the A/Wyoming /2003 strain and were able to isolate several
mutants. Analysis of the mutants isolated in the presence of clone
F004-136 revealed that in all cases K145Q was found, that is, lysine at
the amino acid residue 145 was changed to glutamine. Escape
mutants isolated in the presence of IgG1 of clone F004-104 showed
two kinds of mutations: Y159N and D190E, that is, in one mutantFig. 1. The binding activity and the neutralizing activity of 113 unique mAbs isolated from
examined. The results of 113 mAbs classiﬁed into group 1 to group 31 in category 1 that had
New York/55/04, respectively. Three of the 113 clones, F029-076, F004-144 and F033-224, d
the other clones belonging to the same group as the respective clones showed the neutraliz
unique VH sequence; Clone: clone name. Binding: binding activity measured by ELISA. When
value was between 0.5 and 1.0, it was marked by orange. When the value was between 0.1
focus reduction test. When higher than 50% reduction at 100 μg/ml was observed, it wasmar
by blue. When the degree of reduction was between 15 and 30%, it was marked by light b
column. +, HA-binding signal positive; −, positive signal but not HA; nd, no signal.tyrosine was changed to asparagine at the amino acid residue 159
while in the secondmutant aspartic acid was changed to glutamic acid
at the amino acid residue 190.
Discussion
Our present study aimed to reveal what kinds of mAbs that could
neutralize H3N2 inﬂuenza viruses are present in man. In order to
achieve this purposewe collected a large number of B lymphocytes of a
pediatrician by apheresis who had been repeatedly exposed to the
virus, constructed large Ab libraries by using the phage-display system,
and isolated mAbs that bound to H3N2 viruses. It had been suspected
that since a minor portion of the clones in the library constructed by
combinatorially mixing H and L chains corresponded to mAbs with
original H and L chain pairs present in vivo, the strain speciﬁcity
showed by clones isolated from the phage library may not correctly
reﬂect that by the in vivo mAbs (Gherardi and Milstein, 1992).
However,most of the clones belonging to a single group showed nearly
identical or similar strain speciﬁcity among them both in ELISA and inthe 2004 library. The binding and neutralizing activities to the 12 H3N2 strains were
neutralizing activity were indicated. The number 68 to 04 indicated A/Aichi/2/68 to A/
id not show the neutralizing activity. However, they were listed in this ﬁgure since all of
ing activity. A: group number; B: number of isolated clones; C: number of clones with
the OD value at 492 nm in ELISA was higher than 1.0, it was marked by red. When the
and 0.5, it was marked by yellow. Neutralization: neutralizing activity measured by the
ked by dark blue. When the degree of reduction was between 30 and 50%, it wasmarked
lue. The HA-binding activity examined by Western blot was indicated in the right end
Fig. 3. The binding activity of 68 unique mAbs isolated from the 2007 library. The binding activity to viral proteins of 12 strains was indicated. The results were presented in the same
way as in Fig. 1. The HA-binding activity examined by Western blot was also indicated. +/− indicated very weak positive signal.
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genes of clones belonging to the same group were identical or similar
to one another in most cases (Supplementary Fig. 1) although it wasimpossible to knowwhich pair betweenVH andVL corresponded to the
in vivo pair. Thus, we could expect that the Ag speciﬁcity analyzed in
this study correctly reﬂected that by the in vivo clones.
Fig. 4. Virus-neutralizing activity. (A) Virus-neutralizing activity by IgG1 form and Fab-
PP form of mAbs was measured at various concentrations. Left: clone F004-104; right:
clone F004-136. A/Wyoming/2003 strain was used as a target virus. (B) Virus-
neutralizing activity of IgG1 form of mAbs was measured against 12 kinds of H3N2
strain and one H1N1 strain. Left: clone F004-104; right: clone F004-136.
327J. Okada et al. / Virology 397 (2010) 322–330Approximately 109 B lymphocytes that probably represented 0.1–
1% of his total B cells were collected by apheresis. It could also be
addressed that how much degree of the in vivo Ab repertoire could
have been covered by the B cells collected. We collected B cells twice
at 3-year intervals (2004 and 2007). Each of the two combinatorial
Fab libraries contained around 3×1010 clones. The sequences of
clones isolated from the 2007 library were compared with those from
the 2004 library and 69% of them turned out to belong to one of the 65
groups that had been formed by the clones from the 2004 library.
Therefore, it seemed to be unlikely that the clones isolated in this
study covered only a small part of the in vivo repertoire.
When the strain speciﬁcity of binding activity assayed by ELISA
was compared with that of neutralizing activity assayed by focus
reduction test for respective clones, they were roughly similar to each
other but the range of strains that could be neutralized appeared to be
narrower than that of strains that could be bound in some cases (Fig.
1). This apparent discrepancy between the binding and neutralizing
activities could be due to low sensitivity of neutralizing assay using
monovalent Fab form of Ab as suggested in the examples shown by
comparison between Figs. 1 and 4.
It has been known that mutations accumulated mainly in the ﬁve
regions (A, B, C, D and E) distributed in HA1 that include neutralizing
epitopes (Underwood, 1982; Wiley et al., 1981). The amino acid
sequences of HA1 in the 12 H3 strains used in this study were
compared among them. Fig. 5 indicated the amino acids at the speciﬁc
50 residues in HA1 where mutations were introduced during 36 years
from 1968 to 2004. The analysis of escape mutants suggested that
clone F004-136 bound to A region including lysine located at the
amino acid residue 145 or to other region inﬂuenced by this residue
and that clone F004-104 bound to B region including both tyrosine at
the amino acid residue 159 and aspartic acid at the amino acid residue190 or other region inﬂuenced by these residues. These observations
appeared to be in agreement with the distribution of amino acids at
the relevant positions in the 12 strains. While F004-136 neutralized
three strains 1997, 1999 and 2003, lysine located at the amino acid
residue 145 was found only in these three among the 12 strains.
Similarly, while F004-104 neutralized four strains 1993, 1997, 1999
and 2003, tyrosine located at the amino acid residue 159 was found in
these four strains and the 1985 strain. Aspartic acid located at the
amino acid residue 190 was found in these four strains as well as in
the 2004 strain. The strains that possessed both tyrosine and aspartic
acid at the amino acid residues 159 and 190, respectively, were only
the four strains 1993, 1997, 1999 and 2003 among the 12 strains. As
indicated in these examples the strain speciﬁcity of respective mAbs
will be in agreement with the combination of amino acids at the
critical residues.
Virtually all the clones that showed neutralizing activity were anti-
HA mAbs. Although the clone of group 30 did not give a typical signal
as HA in Western blot, the position of major band at 250 kb might
correspond to that of HA trimer. Furthermore aweak band around 130
kb was found also in several cases of other anti-HA clones. Thus, it is
possible that the epitope recognized by group 30 clone could be
formed only by HA trimer under conditions of Western blot.
Supplementary Fig. 1 showed the amino acid sequences of H and L
chains of 153 uniquemAbs isolated from the 2004 library and those of
68 mAbs from the 2007 library. They were compared with the
sequence of relevant germline VH genes. The degree of identity in the
amino acid sequence between germline genes and isolated clones was
indicated. Table 2 summarized the data showing the identity of VH
sequences of the clones isolated from the 2004 library. The data could
be summarized as follows. 1. All the clones in category 1 (group 1–31)
were well mutated. 2. The clones of group 32–36 in category 2 were
also well mutated although the neutralizing activity was not detected.
3. Both the clones of group 41–51 that bound to only 2003 strain and
those of group 52–65 that bound to 2003 and 2004 strains were not or
littlemutated except for group 49, 51, 52 and 65. Since all the clones in
category 1 were anti-HA Abs except for the uncertainty of group 30
and showed neutralizing activity, and furthermore were highly
mutated, it is likely that they corresponded to the mAbs that had
been matured against ﬂu in vivo. Now we are going to focus on these
clones in the ﬁnal part of discussion.
The most distinct results obtained in this study were that the
majority of clones showing the neutralizing activity could be divided
into three groups with distinct strain speciﬁcity: 1968–1973, 1977–
1993 and 1997–2003. The strain speciﬁcity of binding and neutral-
izing activities shown by respective mAbs could be explained by the
differences observed in the epitopes that they recognize. We
compared the amino acid sequences of HA1 of the 12 strains. While
new amino acids were always found in the newly emergent strain, the
largest change was observed between 1973 and 1977 as well as
between 1993 and 1997 as indicated in Fig. 5. Our results might be
interpreted as follows. After outbreak of ‘Hong Kong’ inﬂuenza in
1968, the epitopes recognized by majority of neutralizing Abs were
relatively stable for several years. During the 4 years from 1973 to
1977 many mutations were introduced into such neutralizing
epitopes and a new variant strain started to appear. Since preexisting
Abs that could have neutralized the 1968, 1970 and 1973 strains were
not able to neutralize the new strain anymore, many kinds of Abs that
were able to neutralize it were newly generated. Fig. 1 also indicated
that virtually all of the mAbs that bound and neutralized the 1977 to
1993 strains showed very similar strain speciﬁcity to one another.
These observations suggested that the epitopes recognized by these
neutralizing Abs, mAbs of group 6–19, were stable, in other words not
mutated, during almost 15 years from 1977 to 1993. Although many
mutations were observed also in the 1981, 1985, 1989 and 1993
strains, themAbs showing different range of neutralizing strains other
than these mAbs were not present in the clones isolated in this study.
Fig. 5. Comparison of amino acid sequences of HA1 in the 12 H3 strains used in this study. The amino acids at the 50 residues where mutations were introduced during 36 years from
1968 to 2004were indicated. Five regions, A, B (B1 and B2), C (C1 and C2), D and E, have been identiﬁed to contain neutralizing epitopes.When a new amino acid was observed at the
appearance of a new strain it was indicated by using a different color. When an amino acid was changed but it was backed to the kind which had been already used before, it was
marked by the same color as before. The number of mutated amino acids was indicated by the two different ways at the bottom. Upper: the number of amino acid residues at which
mutation was introduced with the result in change of amino acid from the directly previous strain; lower: the number of amino acid residues that were changed from the directly
previous strain and whose kinds were not present at the locus in all the previous strains.
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Table 2
Identity of VH sequences between germline and respective somatic clones.
Groupa Germline gene nameb Identity (%)c
1 IGHV3-49⁎04 83.3–84.4
2 IGHV4-59⁎02 86.2
3 IGHV1-2⁎02 88.6
4 IGHV4-59⁎04 85.1
5 IGHV3-15⁎05 72.2–90.0
6 IGHV4-31⁎03 79.8–92.1
7 IGHV4-31⁎03 80.9
8 IGHV4-31⁎03 82.0–87.6
9 IGHV4-61⁎01 87.6
10 IGHV4-30-4⁎01 84.3
11 IGHV4-31⁎03 87.6
12 IGHV4-34⁎02 88.5
13 IGHV4-30-4⁎01 86.5
14 IGHV4-30-4⁎01 85.4–91.0
15 IGHV4-31⁎03 86.5
16 IGHV4-59⁎02 80.5
17 IGHV4-30-4⁎01 85.4–93.3
18 IGHV4-30-4⁎01 87.6
19 IGHV3-11⁎01 90.9–92.0
20 IGHV3-33⁎05 84.1–88.6
21 IGHV1-69⁎06 80.7
22 IGHV3-13⁎01 86.2
23 IGHV4-39⁎07 85.4–98.9
24 IGHV4-31⁎03 83.1–88.8
25 IGHV3-48⁎03 89.7–93.2
26 IGHV2-5⁎09 92.1–93.3
27 IGHV2-5⁎09 90.8
28 IGHV1-8⁎01 90.9
29 IGHV3-20⁎01 85.2–96.6
30 IGHV3-9⁎01 88.6
31 IGHV3-48⁎03 92.0
32 IGHV1-18⁎01 85.2
33 IGHV3-11⁎01 87.5
34 IGHV2-5⁎09 84.3–87.6
35 IGHV2-5⁎09 85.4
36 IGHV2-26⁎01 76.4
37 IGHV3-48⁎03 100
38 IGHV3-48⁎03 83.0
39 IGHV1-2⁎02 98.9
40 IGHV4-61⁎03 86.5
41 IGHV3-53⁎02 97.7
42 IGHV3-21⁎02 100
43 IGHV3-48⁎02 100
44 IGHV3-30⁎18 100
45 IGHV1-69⁎13 100
46 IGHV1-69⁎13 100
47 IGHV1-69⁎09 100
48 IGHV1-69⁎09 100
49 IGHV1-2⁎02 93.2
50 IGHV4-4⁎02 100
51 IGHV4-61⁎01 88.8
52 IGHV3-30⁎18 90.9
53 IGHV3-30-3⁎01 100
54 IGHV1-69⁎09 100
55 IGHV1-2⁎02 98.9
56 IGHV1-2⁎02 98.9
57 IGHV1-2⁎02 98.9
58 IGHV1-2⁎02 98.9
59 IGHV1-2⁎02 98.9
60 IGHV1-2⁎02 98.9
61 IGHV1-2⁎02 94.3
62 IGHV1-18⁎01 100
63 IGHV4-34⁎02 100
64 IGHV4-34⁎02 100
65 IGHV4-59⁎01 89.7
a All the 153 unique mAbs isolated from the 2004 library were classiﬁed into 65
groups based on sequence similarities of VH fragments.
b Germline sequences that may correspond to respective somatic clones were
assigned; the actual sequences were indicated in Supplementary Fig. 1.
c Identity of the sequences between germline and somatic sequences were
calculated. Since one to 14 clones were present in respective groups, the identity was
indicated in a range.
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about the antigenic drift driven by presence of neutralizing Abs (Hay
et al., 2001). The newly generated amino acids located at the
neutralizing epitopes under pressure of neutralizing Abs would have
shown strong antigenicity, resulting in generation of B cells that
produce neutralizing mAbs against them. According to this theory the
mAbs showing various ranges of strain speciﬁcity in terms of
neutralizing activity should have existed. Thus, our results might
reﬂect the exaggerated situations in which the growth of B cell clones
producing mAbs against stable epitopes were stimulated, and the
number of such cells was largely enhanced in man who had been
exposed to ﬂu on numerous occasions every year.
Materials and methods
Construction of Ab library
Mononuclear cells were collected by apheresis from the equivalent
of 3 l of blood of an individual. It contained approximately 109 B
lymphocytes. Using the phage-display method large combinatorial Ab
libraries were constructed as described (Marks et al., 1991). The
number of clones established for H chain genes was about 109 and
that of L chain genes was around 106. The genes encoding the Fab form
of Ab fused with a truncated cp3 (Fab-cp3) were constructed by
combinatorially combining V region of H chain (VH) and that of L
chain (VL) genes (Iba et al., 1997) and the resulting Ab libraries were
composed of 3–4×1010 clones.
Inﬂuenza strains
The following 12 different H3 strains isolated between 1968 and
2004 were used for screening and characterization of the clones: A/
Aichi/2/68, A/Fukuoka/1/70, A/Tokyo/6/73, A/Yamanashi/2/77, A/
Niigata/102/81, A/Fukuoka/C29/85, A/Guizhou/54/89, A/Kita-
kyushu/159/93, A/Sydney/5/97, A/Panama/2007/99, A/Wyoming/
3/2003, and A/New York/55/2004. A H1 strain, A/New Caledonia/
20/99, was used for comparison.
Screening of the library
Selection of phages bound to virus particles was performed by a
panning method as described previously (Marks et al., 1991; Iba et al.,
1997). Formalin-treated virus particles were used as Ags in the
screenings. After three time pannings the phages eluted were infected
to E. coli (DH12S) and spread to the LB plate containing 100 μg/ml
ampicillin and 0.2% glucose. Colonies were picked up. When E. coli
with phagemid was grown without helper phages overnight, Fab-cp3
form of Ab was secreted into medium (Morino et al., 2001). The
supernatant containing Fab-cp3 molecules was subjected to ELISA
against various strains of inﬂuenza viruses including H1 strain. Clones
that bound only to H3 strains were selected.
Sequence analysis
The nucleotide sequences of VH and VL regions were determined
with a CEQ2000 DNA Analysis System (BECKMAN COULTER) by using
GenomeLab Dye Terminator Cycle Sequencing with Quick Start Kit
(BECKMAN COULTER). The T7ETZ primer (5′-TAATACGACTCACTA-
TAGGG-3′) and the huCH1J primer (5′-ATTAATAAGAGCTATCCCGG-
3′) were used for VH and VL sequencing, respectively.
Preparation of various forms of Ab
The Fab-cp3 molecules in the supernatant of E. coli culture
were used for ELISA without puriﬁcation (Morino et al., 2001). After
Fab-cp3 molecules were converted into Fab-PP (P denotes a single
330 J. Okada et al. / Virology 397 (2010) 322–330Fc-binding domain of protein A) formof Abs (Ito andKurosawa, 1993),
they were puriﬁed with an IgG-conjugated column. Puriﬁed Fab-PP
molecules were used for assay of neutralizing activity and forWestern
blot. IgG1 was prepared using a high expression vector (Bebbington
et al., 1992) and puriﬁed with a Protein G-conjugated column.
ELISA
Inactivated-virus particles were coated onto immunoplates (96-
well; Nalgen Nunc international). After blocking with 5% BSA the
plates were incubated with Fab-cp3. For detection rabbit anti-cp3 Ab
(MBL) was used as the ﬁrst Ab and peroxidase-conjugated goat anti-
rabbit IgG (H + L chain; MBL) was used as the second Ab. Finally HRP
substrate (OPD; Wako) was added and OD at 492 nm was measured.
Neutralization test
Neutralizing activity was measured by the focus reduction test as
described previously (Nakagawa et al., 2001). In the case of Fab-pp
form of Ab, 20, 100 and 250 μg/ml were used. When higher than 30%
reduction at 100 μg/ml (it corresponded to 1.5 μM) was observed, we
considered that it showed neutralizing activity.
Western blot
Formalin-inactivated virus particles used as Ag in the screenings
were separated by SDS–PAGE under nonreducing conditions and
transferred to Immobilon-P membrane (Millipore). Membranes were
blocked with PBS containing 2.5% skim milk and incubated with Fab-
PP form of Ab. After incubation with peroxidase-conjugated rabbit
anti-streptavidin Ab, immunoreactive bands were visualized using
ECL Plus Western blotting Detection Regents (GE Healthcare) and a
Chemical-luminescence imaging system (Light Capture; ATTO).
Isolation of escape mutants
Escape mutants were induced by incubating A/Wyoming/3/2003
with IgG1 Ab with a modiﬁcation of the method previously described
(Nakagawa et al., 2003). Brieﬂy, 1×105 focus forming units/ml of virus
was incubated for 1 h at 37 °C in the presence of 5 μg of Ab. The virus–
Ab mixture was inoculated to MDCK cells in 24-well plates and
incubated at 35 °C for 3 days. Theneutralization tests on eachwellwere
performed separately with Abs in order to identify the escapemutants.
The nucleotide sequence of the escape mutants was determined by
using the following primers: H3HA forward, 5′-GCAAAAGCAGGGGA-
TAATTCT; H3HA backward, 5′-GTAGAAACAAGGGTGTTTTTAATTA;
H3HA 568, 5′-TGAACGTGACTATGCCAAACAATG.
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Appendix A. Supplementary data
Supplemental Fig. 1 Amino acid sequences of VH and VL of 153
unique mAbs isolated from the 2004 library and those of 68 mAbs
from the 2007 library. All the 153 mAbs from the 2004 library were
classiﬁed into 65 groups based on sequence similarities of VH
fragments. Germline sequences that may correspond to respectivesomatic clones were assigned and indicated. Identity % indicates the
degree of identity between germline and somatic sequences of VH
gene-encoding regions other than those covered by primers.
Sequences of the 68 clones from the 2007 library were compared
with those from the 2004 library. They were shadowed. When they
could be classiﬁed into one of the above 65 groups, the sequences
were presented together in the corresponding group. The clones from
the 2007 library that did not overlap with any of the clones isolated
from the 2004 library were separately indicated at the end.
Supplementary Fig. 2 Western blot of clones belonging to category
1. Representative clones of group 1–31 were subjected to Western
blot to examine whether they were anti-HA mAbs. Group number,
the name of a representative clone and the name of H3 strain used
in the Western blot were indicated on the top of each photograph.
For the positive control anti-HA mouse IgG was used. All the clones
turned out to be anti-HA mAbs except for clone of group 30. It was
still possible that group 30 mAb could also be anti-HA clone (see
Discussion).
Note: The supplementary material accompanying this article is
available at (doi:10.1016/j.virol.2009.11.025).
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